Search Results
2. Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease
3. Focus on the target: the tumor microenvironment, Society for Immunotherapy of Cancer Annual Meeting Workshop, October 24th-25th 2012
4. Immunotargeting of tumor vasculature: preclinical development of novel antibody-based imaging and therapy against TEM1/CD248
5. Inhibition of Caveolin-1 Restores Myeloid Cell Function in Human Glioblastoma
6. Statistical issues and challenges in immuno-oncology
7. The role of surgery following incomplete response to high-dose IL-2 (HD IL-2)
8. A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
9. Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition
10. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
- « Previous
- Next »
- 1
- 2
- 3